Skip to main content
. Author manuscript; available in PMC: 2015 Feb 1.
Published in final edited form as: Neuropharmacology. 2013 Oct 3;77:10.1016/j.neuropharm.2013.09.023. doi: 10.1016/j.neuropharm.2013.09.023

Table 2. Binding affinity of selected compounds at the human α3β4α5 nAChR using [125I]AT-1012 and [3H]epibatidine as radioligands.

Binding was conducted as described in Materials and Methods. Data show average ± SD from at least 2 experiments conducted in triplicate for [3H]epibatidine binding and quadruplicate for [125I]AT-1012 binding. In each cell, the upper line is the Ki and the lower line, in parentheses, is the Hill coefficient. [125I]AT-1012 does not have specific binding to α4β2 nAChR.

Binding affinity (Ki nM) at human α3β4α5 nAChR
Compound [125I]AT-1012 [3H] epibatidine
Epibatidine 1.10±0.04
(0.88±0.02)
0.58±0.02
(0.98±0.02)
Nicotine 1305±219
(0.75±0.05)
1573±35
(0.91±0.04)
AT-1001 1.75±0.14
(0.95±0.05)
3.34±0.03
(0.82±0.04)
AT-1012 0.68±0.06
(0.96±0.09)
1.08±0.05
(0.81 ±0.0 3)